Volume 11, number 1
 Views: (Visited 72 times, 1 visits today)  

Devi C. S, Modi M. A, Unnikrishnan U, Mohanasrinivasan V. A Review on Chikungunya and Suggesting a Hypothesis of Nano-based Drug Delivery. Biosci Biotechnol Res Asia 2014;11(1)
Manuscript received on : 
Manuscript accepted on : 
Published online on:  06-02-2016
How to Cite    |   Publication History    |   PlumX Article Matrix

A Review on Chikungunya and Suggesting a Hypothesis of Nano-based Drug Delivery

 

C. Subathra Devi*, Megha A Modi, Unnma Unnikrishnan and V. Mohanasrinivasan

 

School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India

 

ABSTRACT:

Chikungunya gained insight by the 2006 epidemic seen in India and Islands of the Indian Ocean and since then it has become a major disease with no commercial vaccine available. A number of epidemiological studies have been done to trace back the evolution of the Chikungunya Virus (CHIKV) and the reasons which led to the re-emergence of the epidemic & the spread of disease across borders which pose threat in the future as seen before. In this review, based on epidemiological data available several parameters of clinical importance are being analysed and a hypothetical cure is proposed based on the mechanism of action of virus and its life cycle and the use of nano-encapsulation for efficient delivery of the drug.

 

KEYWORDS:

Chikungunya; CHIKV; Epidemiology; Nano-encapsulation

Download this article as: 
Copy the following to cite this article:

Devi C. S, Modi M. A, Unnikrishnan U, Mohanasrinivasan V. A Review on Chikungunya and Suggesting a Hypothesis of Nano-based Drug Delivery. Biosci Biotechnol Res Asia 2014;11(1)

Copy the following to cite this URL:

Devi C. S, Modi M. A, Unnikrishnan U, Mohanasrinivasan V. A Review on Chikungunya and Suggesting a Hypothesis of Nano-based Drug Delivery. Biosci Biotechnol Res Asia 2014;11(1). Available from: https://www.biotech-asia.org/?p=6483

(Visited 72 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.